Novel cross-reactive anti-idiotype antibodies with properties close to the human intravenous immunoglobulin (IVIg)

Hybridoma

Volumn 18, Issue 3, 1999, Pages 263-272

  Macias, A ^a   Arce, S ^a   Leon, J ^a   Mustelier, G ^a   Bombino, G ^a   Domarco, A ^a   Perez, R ^a   Lage, A ^a  

^a CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS REACTING ANTIBODY; IDIOTYPIC ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CELL DIVISION; CELL LINE; CROSS REACTIONS; G(M2) GANGLIOSIDE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN IDIOTYPES; IMMUNOGLOBULINS, INTRAVENOUS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, NUDE; T-LYMPHOCYTES;

ANIMALIA;

EID: 0032782583     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/027245799315925     Document Type: Article

References (55)

1. Varela FJ, and Coutinho A: Second generation immune networks. Immunol Today 1991;12:159-166.
2. Stewart J: Autoimmunity and idiotypic networks. In: Autoimmunity Physiology and Disease. Coutinho A and Kazatchkine MD (Eds.). Wiley-Liss, Inc., New York, 1994, pp. 229-240.
3. Avrameas S: Natural autoantibodies: from "horror autotoxicus" to "gnothi seauton." Immunol Today 1991;12:154-159.
4. Dighiero G, Lymberi P, Mazié JC, Rouyre S, Buttler-Browne GS, Whalen RG, and Avrameas S: Murine hybridomas secreting natural monoclonal antibodies reacting with self antigens. J. Immunol 1983;131:2267-2272.
5. Baccala R, Vo Quang T, Glibert M, Ternynck T, and Avrameas S: Two murine natural polyreactive autoantibodies are encoded by non-mutated germ-line genes. Proc Natl Acad Sci USA 1989;86:4624-4628.
6. Dighiero G, Lymberi P, Holmberg D, Lundquist I, Coutinho A, and Avrameas S: High frequency of natural autoantibodies in normal newborn mice. J Immunol 1985;134:765-771.
7. Seigneurin JM, Guilbert B, Bourgeat MJ, and Avrameas S: Polyspecific natural antibodies and autoantibodies secreted by human lymphocytes immortalized with Epstein-Barr virus. Blood 1988;71:581-585.
8. Avrameas S, Guilbert B, and Dighiero G: Natural antibodies against tubulin, actin, myoglobulin, thyroglobulin, fetuin, albumin and transferrin are present in normal sera and monoclonal immunoglobulins from multiple myeloma and Waldenstrom's macroglobulinemia may express similar antibody specificities. Ann Immunol (Inst. Pasteur) 1981;132C:231-236.
9. Avrameas S, and Ternynck T: The natural autoantibodies system: Between hypothesis and facts. Mol Immunol 1993;30:1133-1142.
10. Hentati B, Ternynck T, Avrameas S, and Payelle-Brogard B: Comparison of natural antibodies to autoantibodies arising during lupus in (NZB X NZW) F1 mice. J Autoimmun 1991;4:341-356.
11. Andersson A, Forsgren S, Söderström A, and Holmberg D: Monoclonal, natural antibodies prevent development of diabetes in the non-obese diabetic (NOD) mouse. J Autoimmun 1991;4:733-742.
12. Sunblad A, Hauser S, Holmberg D, Cazenave PA, and Coutinho A: Suppression of antibody responses to the acetylcholine receptor by natural antibodies. Eur J Immunol 1989;19:1425-1430.
13. Chow DA, and Bennet RD: Low natural antibody and low in vivo tumor resistance, in xid-bearing B-cell deficient mice. J Immunol 1989;142:3702-3706.
14. Ternynck T, and Avrameas S. Murine natural monoclonal autoantibodies: A study of their polyspecificities and their affinities. Immunol Rev 1986;96:99-112.
15. Martin T, Crouzier R, Weber JC, Kipps JT, and Pasquali JL: Structure-function studies on a polyreactive (natural) autoantibody. J Immunol 1994;152:5988-5996.
16. Dietrich G, Kaveri SV, and Kazatchine MD: Modulation of autoimmunity by intravenous immunoglobulin through interaction with the function of the immune/idiotypic network. Clin Immunol Immunopathol 1992;62:S73-S81.
17. Sunblad A, Marcos ARM, Malanchere E, Castro A, Haury M, Huetz F, Nobrega A, Freitas A, and Coutinho A: Observations on the mode of action of normal immunoglobulin at high doses. Immunol Rev 1994;139:125-158.
18. Svennerholm L: Ganglioside isolation. Methods Carbohydr Chem 1976;6:464-474.
19. Alfonso M, Vázquez AM, Carr A, Haerslev T, Fernández LE, Lanio ME, Alvarez C, Zeuthen J, and Pérez R: T-cell independent B-cell response to self monosialogangliosides: Primary response monoclonal antibodies. Hybridoma 1995;14:209-216.
20. Harlow E, and Lane D: Antibodies: A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Habor, NY, 1988.
21. Ey PL, Prowse SJ, and Jenkin CR: Isolation of pure IgG1. IgG2a and IgG2b immunoglobulin from mouse serum using protein A-Sepharose. Immunochemistry 1979;15:429-436.
22. Holmberg D, Forsgren S, Ivars F, and Coutinho A: Reactions among IgM antibodies derived from normal neonatal mice. Eur J Immunol 1984;14:435-441.
23. Raychaudhuri S, Saeki Y, Fuji H, and Köhler H: Tumor-specific idiotype vaccines I. Generation and characterization of internal image tumor antigen. J Immunol 1986;137:1743-1749.
24. Bayer EA, and Wilchek M: The use of avidin-biotin complex as a tool in molecular biology. Methods Biochem Anal 1980;26:1-45.
25. 2 fragments from mouse IgG of various subclasses. J Immunol Methods 1983; 56:235-243.
26. Ando DG, Sercarz EE, Hahn BH: Mechanisms of T and B collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model. J Immunol 1987;138: 3185-3190.
27. Klaesson S, Ringdén O, Markling L, Remberger M, and Lundkvist I: Immune Modulatory effects of immunoglobulins on cell-mediated immune responses in vitro. Scand J Immunol 1993; 38:477-484.
28. Shick MR, Dreesman GR, and Kennedy RC: Induction of an anti-hepatitis B surface antigen response in mice by non-internal image (Ab2α anti-idiotypic antibodies. J Immunol 1987;138:3419-3425.
29. Kennedy RC, Dreesman GR, Butel JS, and Lanford RE: Supression of the in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving anti-idiotypic antibodies. J Exp Med 1987;161:1432-1438.
30. Sacks DL, and Sher A: Evidence that anti-idiotype indued to experimental African trypanosomiasis is genetically restricted and requires recognition of combining site-related idiotopes. J Immunol 1983;131:1511-1517.
31. Huang J-H, Ward RE, and Köhler H: Idiotope antigens (Ab2α and Ab2β) can induce in vitro B cell proliferation and antibody production. J Immunol 1986;137:770-776.
32. Holmberg D, Wennestrom G, Andrade L, and Coutinho A: The high idiotypic connectivity of "natural" newborn antibodies is not found in adult mitogen-reactive B cell repertories. Eur J Immunol 1986;16:82-87.
33. Ditzel JH, Barbas MS, Barbas III FC, Burton RD: The nature of the autoimmune antibody repertoire in human immunodeficiency virus type 1 infection. Proc Natl Acad Sci USA 1994;91: 3710-3714.
34. Richalet P SM, Laurent-Crawford A, Barakat S, Riviere Y, Chamaret S, Briant JP, Montagnier L, Hovanessian A: Autoantibodies typical of non-organ-specific autoimmune diseaes in HIV-seropositive patients. AIDS 1992;6:933-942.
35. Sablitzky F, and Rajewsky K: Molecular basis of an isogenic anti-idiotypic response. EMBO J 1984;3:3005-3012.
36. Dildrop R, Bovens J, Siekevitz M, Beyreuther K, and Rajewsky K: A V region determinant (idiotope) expressed at high frequency in B lymphocytes is encoded by a large set of antibody structural genes. EMBO J 1984;3:517-523.
37. Ternynck T, Bleux C, Grégoire J, Avrameas S, and Kanellopoulos-Langevin C: Comparison between autoantibodies arising during Trypanosoma cruzi infection in mice and natural autoantibodies. J. Immunol 1990;144:1504-1511.
38. Ternynck T, Falanga PB, Unterkircher C, Grégorie J, Pereira da Silva L, and Avrameas S: Induction of high levels of IgG autoantibodies in mice infected with Plasmodium chabaudi. Int Immunol 1991;3:29-37.
39. Adib-Conquy M, Avrameas S, and Trenynck T: Monoclonal IgG and IgM autoantibodies obtained after polyclonal activation, show reactivities similar to those of polyclonal natural autoantibodies. Mol Immunol 1993;30:119-127.
40. Berneman A, Ternynck T, and Avrameas S: Natural mouse IgG reacts with self antigens including molecules involved in the immune response. Eur J Immunol 1992;22:625-633.
41. Lundkvist I, Coutinho A, Varela F, and Holmberg D: Evidence for a functional idiotypic network among natural antibodies in normal mice. Proc Natl Acad Sci USA 1989;86:5074-5078.
42. Cohen IR: The cognitive paradigm and the immunological homunculus. Immunol Today 1992;13:490-494.
43. Cohen IR, and Young DB: Autoimmunity, microbial immunity and the immunological homunculus. Immunol Today 1991; 12:105-110.
44. Cohen IR: Kadishman's tree, Escher's Angels, and the immunological homunculus. In: Autoimmunity Physiology and Disease. Coutinho A and Kazatchkine MD (Eds.). Wiley-Liss, Inc., New York, 1994, pp. 7-18.
45. Coutinho A: Beyond clonal selection and network. Immunol Rev 1989;110:63-87.
46. Abe Y, Horiuchi A, Miyake M, and Kimura S: Anti-cytokine nature of natural human immunoglobulin: One possible mechanism of the clinical effect of intravenous immunoglobulin. Immunol Rev 1994;139:5-19.
47. Andersson U, Björk L, Skansén-Saphir U, and Andersson J: Pooled Human IgG modulates cytokine production in lymphocytes and monocytes. Immunol Rev 1994;139:21-42.
48. Dinarrello AC: Is there a Role for Interleukin-1 blockade in intravenous immunoglobulin therapy? Immunol Rev 1994;139: 173-188.
49. Kazatchikne MD, Dietrich G, Hurez V, Ronda N, Bellon B, Rossi F, and Kaveri SV: V-region-mediated selection of autoreactive repertories by intravenous immunoglobulin (i.v.Ig). Immunol Rev 1994;139:79-107.
50. Kaveri SV, Dietrich G, Hurez V, and Kazatchikne MD: Intravenous immunoglobulins (IVIg) in the treatment of autoimmune disease. Clin Exp Immunol 1991;86:192-198.
51. Mazel MS, Rudensky YA, and Yurin LV: Immunoglobulin-specific T-B cell interaction III. B cell activation by immunoglobulin recognizing T cell clones. Eur J Immunol 1990;20:833-839.
52. Ebling MF, Tsao PB, Singh RR, Secarz E, and Hahn HB: A peptide derived from an autoantibody can stimulated T cells in the (NZBXNZW) F1 mouse model of Systemic Lupus Erythematosus. Arthritis and Rheum 1993;36:335-364.
53. Singh RR, Ebling MF, Sercaz EE, and Hahn HB: Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine Lupus. J Clin Invest 1995;96:2990-2996.
54. Singh Rr, Kumar V, Ebling MF, Southwood S, Sette A, Sercarz EE, and Hahn BH: T cell determinants from autoantibodies to DNA can up-regulate autoimmunity in murine Systemic Lupus Erythematosus. J Exp Med 1995;81:2017-2027.
55. Singh RR, Hahn HB, Tsao PB, and Ebling MF: Evidence for multiple mechanisms of polyclonal T cell activation in murine Lupus. J Clin Invest 1998;102:1841-1849.